5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C114H136BBr2ClN22O16 — CID 157349167

About 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (PubChem CID 157349167) has the molecular formula C114H136BBr2ClN22O16 and a molecular weight of 2276.55 g/mol. Its IUPAC name is 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine.

Molecular Properties

• Compound Name: 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
• PubChem CID: 157349167
• Molecular Formula: C114H136BBr2ClN22O16
• Molecular Weight: 2276.55 g/mol
• Exact Mass: 2272.87
• IUPAC Name: 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
• SMILES: CC(C)(C)OC(=O)N1CCCC(Oc2cncc(-c3nn(C4CCCCO4)c4ccc(Br)cc34)n2)C1.COc1cncc(-c2ccc3[nH]nc(-c4cncc(OC5CCCNC5)n4)c3c2)c1.COc1cncc(-c2ccc3c(c2)c(-c2cncc(OC4CCCN(C(=O)OC(C)(C)C)C4)n2)nn3C2CCCCO2)c1.COc1cncc(B2OC(C)(C)C(C)(C)O2)c1.Clc1cncc(-c2nn(C3CCCCO3)c3ccc(Br)cc23)n1.OC1CCCCC1
• InChI: InChI=1S/C32H38N6O5.C26H32BrN5O4.C22H22N6O2.C16H14BrClN4O.C12H18BNO3.C6H12O/c1-32(2,3)43-31(39)37-12-7-8-23(20-37)42-28-19-34-18-26(35-28)30-25-15-21(22-14-24(40-4)17-33-16-22)10-11-27(25)38(36-30)29-9-5-6-13-41-29;1-26(2,3)36-25(33)31-11-6-7-18(16-31)35-22-15-28-14-20(29-22)24-19-13-17(27)9-10-21(19)32(30-24)23-8-4-5-12-34-23;1-29-17-7-15(9-24-11-17)14-4-5-19-18(8-14)22(28-27-19)20-12-25-13-21(26-20)30-16-3-2-6-23-10-16;17-10-4-5-13-11(7-10)16(12-8-19-9-14(18)20-12)21-22(13)15-3-1-2-6-23-15;1-11(2)12(3,4)17-13(16-11)9-6-10(15-5)8-14-7-9;7-6-4-2-1-3-5-6/h10-11,14-19,23,29H,5-9,12-13,20H2,1-4H3;9-10,13-15,18,23H,4-8,11-12,16H2,1-3H3;4-5,7-9,11-13,16,23H,2-3,6,10H2,1H3,(H,27,28);4-5,7-9,15H,1-3,6H2;6-8H,1-5H3;6-7H,1-5H2
• InChIKey: BHICMCOBTNSGOG-UHFFFAOYSA-N
• XLogP: 22.30
• TPSA: 416.80 Ų
• H-Bond Donors: 3
• H-Bond Acceptors: 35
• Rotatable Bonds: 19
• Heavy Atoms: 156
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2276.55
LogP ≤ 5	22.30
H-Bond Donors ≤ 5	3
H-Bond Acceptors ≤ 10	35

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine?

The IUPAC name of 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (CID 157349167) is 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine.

What is the SMILES notation for 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine?

The canonical SMILES for 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is CC(C)(C)OC(=O)N1CCCC(Oc2cncc(-c3nn(C4CCCCO4)c4ccc(Br)cc34)n2)C1.COc1cncc(-c2ccc3[nH]nc(-c4cncc(OC5CCCNC5)n4)c3c2)c1.COc1cncc(-c2ccc3c(c2)c(-c2cncc(OC4CCCN(C(=O)OC(C)(C)C)C4)n2)nn3C2CCCCO2)c1.COc1cncc(B2OC(C)(C)C(C)(C)O2)c1.Clc1cncc(-c2nn(C3CCCCO3)c3ccc(Br)cc23)n1.OC1CCCCC1.

What is the InChIKey of 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine?

The InChIKey is BHICMCOBTNSGOG-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H38N6O5.C26H32BrN5O4.C22H22N6O2.C16H14BrClN4O.C12H18BNO3.C6H12O/c1-32(2,3)43-31(39)37-12-7-8-23(20-37)42-28-19-34-18-26(35-28)30-25-15-21(22-14-24(40-4)17-33-16-22)10-11-27(25)38(36-30)29-9-5-6-13-41-29;1-26(2,3)36-25(33)31-11-6-7-18(16-31)35-22-15-28-14-20(29-22)24-19-13-17(27)9-10-21(19)32(30-24)23-8-4-5-12-34-23;1-29-17-7-15(9-24-11-17)14-4-5-19-18(8-14)22(28-27-19)20-12-25-13-21(26-20)30-16-3-2-6-23-10-16;17-10-4-5-13-11(7-10)16(12-8-19-9-14(18)20-12)21-22(13)15-3-1-2-6-23-15;1-11(2)12(3,4)17-13(16-11)9-6-10(15-5)8-14-7-9;7-6-4-2-1-3-5-6/h10-11,14-19,23,29H,5-9,12-13,20H2,1-4H3;9-10,13-15,18,23H,4-8,11-12,16H2,1-3H3;4-5,7-9,11-13,16,23H,2-3,6,10H2,1H3,(H,27,28);4-5,7-9,15H,1-3,6H2;6-8H,1-5H3;6-7H,1-5H2.

What are the key properties of 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine?

5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine has a molecular weight of 2276.55 g/mol, XLogP of 22.30, 19 rotatable bonds, 3 hydrogen bond donors, and 35 hydrogen bond acceptors.

Where does this data come from?

All data for 5-bromo-3-(6-chloropyrazin-2-yl)-1-(oxan-2-yl)indazole;tert-butyl 3-[6-[5-bromo-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;tert-butyl 3-[6-[5-(5-methoxy-3-pyridinyl)-1-(oxan-2-yl)indazol-3-yl]pyrazin-2-yl]oxypiperidine-1-carboxylate;cyclohexanol;5-(5-methoxy-3-pyridinyl)-3-(6-piperidin-3-yloxypyrazin-2-yl)-1H-indazole;3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is sourced from PubChem (CID 157349167), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).